Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.
De Marinis F, Rinaldi M, Ardizzoni A, Bruzzi P, Pennucci MC, Portalone L, D'Aprile M, Ripanti P, Romano F, Belli M, Altavilla G, Migliorino MR, Rosso R, Salvati F. De Marinis F, et al. Tumori. 1999 May-Jun;85(3):177-82. doi: 10.1177/030089169908500306. Tumori. 1999. PMID: 10426128 Clinical Trial.
Neoadjuvant strategies for non-small cell lung cancer.
De Marinis F, Migliorino MR, Mancuso A, De Petris L, Belli R. De Marinis F, et al. Among authors: de petris l. Suppl Tumori. 2004 Mar-Apr;3(2):S49-51. Suppl Tumori. 2004. PMID: 15067968 Review. No abstract available.
Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.
Portalone L, Antilli A, Nunziati F, Crispino C, de Marinis F, Friggeri L, Lombardi A, Lorusso V, Pronzato P, Sambiasi D, Signora M; Associazione Italiana Pneumologi Ospedalieri Thoracic Oncology Study Group. Portalone L, et al. Among authors: de marinis f. Tumori. 2005 Jan-Feb;91(1):15-8. doi: 10.1177/030089160509100104. Tumori. 2005. PMID: 15849999 Clinical Trial.
381 results